245 related articles for article (PubMed ID: 19528221)
1. Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.
Leong ML; Hampl J; Liu W; Mathur S; Bahjat KS; Luckett W; Dubensky TW; Brockstedt DG
Infect Immun; 2009 Sep; 77(9):3958-68. PubMed ID: 19528221
[TBL] [Abstract][Full Text] [Related]
2. Selected prfA* mutations in recombinant attenuated Listeria monocytogenes strains augment expression of foreign immunogens and enhance vaccine-elicited humoral and cellular immune responses.
Yan L; Qiu J; Chen J; Ryan-Payseur B; Huang D; Wang Y; Rong L; Melton-Witt JA; Freitag NE; Chen ZW
Infect Immun; 2008 Aug; 76(8):3439-50. PubMed ID: 18474644
[TBL] [Abstract][Full Text] [Related]
3. A combined use of autolysin p60 and listeriolysin O antigens induces high protective immune responses against Listeria monocytogenes infection.
Luo X; Cai X
Curr Microbiol; 2012 Dec; 65(6):813-8. PubMed ID: 23001425
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
[TBL] [Abstract][Full Text] [Related]
5. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
[TBL] [Abstract][Full Text] [Related]
6. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
[TBL] [Abstract][Full Text] [Related]
7. Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants.
Bouwer HG; Gibbins BL; Jones S; Hinrichs DJ
Infect Immun; 1994 Mar; 62(3):1039-45. PubMed ID: 7509313
[TBL] [Abstract][Full Text] [Related]
8. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein.
Baloglu S; Boyle SM; Vemulapalli R; Sriranganathan N; Schurig GG; Toth TE
Vet Microbiol; 2005 Aug; 109(1-2):11-7. PubMed ID: 15941627
[TBL] [Abstract][Full Text] [Related]
9. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
Vaccine; 2008 Sep; 26(41):5304-14. PubMed ID: 18691625
[TBL] [Abstract][Full Text] [Related]
10. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO.
Safley SA; Cluff CW; Marshall NE; Ziegler HK
J Immunol; 1991 May; 146(10):3604-16. PubMed ID: 1709197
[TBL] [Abstract][Full Text] [Related]
11. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
[TBL] [Abstract][Full Text] [Related]
12. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine.
Schafer R; Portnoy DA; Brassell SA; Paterson Y
J Immunol; 1992 Jul; 149(1):53-9. PubMed ID: 1607662
[TBL] [Abstract][Full Text] [Related]
13. Listeriolysin O-deficient Listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity.
Hamilton SE; Badovinac VP; Khanolkar A; Harty JT
J Immunol; 2006 Sep; 177(6):4012-20. PubMed ID: 16951364
[TBL] [Abstract][Full Text] [Related]
14. Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response.
Bouwer HG; Shen H; Fan X; Miller JF; Barry RA; Hinrichs DJ
Infect Immun; 1999 Jan; 67(1):253-8. PubMed ID: 9864223
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a Lactococcus lactis ΔpyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
Bioeng Bugs; 2010; 1(1):66-74. PubMed ID: 21327128
[TBL] [Abstract][Full Text] [Related]
16. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
[TBL] [Abstract][Full Text] [Related]
17. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity induced by a LLO-deficient Listeria monocytogenes.
Yin Y; Zhang C; Dong H; Niu Z; Pan Z; Huang J; Jiao X
Microbiol Immunol; 2010 Apr; 54(4):175-83. PubMed ID: 20377746
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of T-cell-reactive protein antigens from Listeria monocytogenes.
Beattie IA; Swaminathan B; Ziegler HK
Infect Immun; 1990 Sep; 58(9):2792-803. PubMed ID: 2117570
[TBL] [Abstract][Full Text] [Related]
20. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
